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1. Introduction 
The machinery regulating the transcription and processing of the human immunodeficiency 
virus type 1 (HIV-1) genome has been extensively studied for the past two decades, leading 
to the characterization of a complex set of interactions between viral and cellular factors. 
Our understanding of the basic molecular mechanisms regulating the expression of cellular 
genes has been greatly advanced by the lessons learned from this virus. Studies aimed at the 
understanding of transcription, capping, polyadenylation, splicing and export of the viral 
transcripts have helped in modeling the mechanisms regulating transcriptional and post-
transcriptional events in the cell. Recent developments in the field have also shown that, 
similarly to cellular genes, transcription and processing of the viral mRNAs are functionally 
coupled and can potentially be regulated by small non-coding RNAs.  
HIV replication is a complex multistep process whereby, following the recognition of 
specific receptors and co-receptors on the host cell membrane, the virus enters the cell where 
the viral RNA genome is reverse transcribed and integrated into the cellular DNA. The 
integrated proviral genome is than transcribed by the host transcription machinery into a 9.2 
kb primary transcript, which is alternatively spliced in mRNAs coding for the 9 viral genes. 
Tat and rev gene products are shuttled into the nucleus to aid the transcription process, the 
former, and export of unspliced transcripts, the later. Unspliced transcripts are packaged as 
viral genome into the nascent virions. Gag and env gene products code for the structural 
components of the new virions while the pol gene codes for key enzyme required for viral 
integration into the target host cell, which are than packaged within the virions. The 
products of the Vif, Vpr, Vpu and Nef genes are not essential for viral replication but are 
required for HIV pathogenesis and infectivity in-vivo. 
HIV-1 has developed a number of strategies to regulate the transcription and processing of 
its primary transcript. Interactions between viral RNA sequences, the host cell and viral 
proteins are necessary to express the nine gene products required for its replication. 
Alteration of the delicate balance between spliced and unspliced RNAs, or disruption of the 
viral RNA export pathway, can dramatically affect HIV-1 infectivity and pathogenesis 
(Amendt, et al., 1994, Jablonski & Caputi, 2009, Pollard & Malim, 1998, Purcell & Martin, 
1993, Stoltzfus & Madsen, 2006, Wentz, et al., 1997). A better understanding of the 
mechanisms regulating the transcription and processing of the viral RNA may provide us 
with novel therapeutic targets.    
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Fig. 1. The HIV-1 replication cycle. The key steps in the viral replication cycle: entry, 
integration, transcription, splicing export and assembly of the new virions are schematically 
shown together with the main viral gene products and their functions. 
2. HIV-1 transcription regulation 
Once the virus is integrated into the host cell chromosome the viral genome is transcribed 
into a single pre-mRNA from a complex promoter located within the 5’ long terminal repeat 
(LTR) of the viral genome. The HIV-1 LTR promoter contains two Sp1 binding motifs and 
two nuclear factor NF-kB binding sites which serves to regulate basal HIV-1 transcription 
(Pereira, et al., 2000). The LTR also contains binding elements for positive nuclear factor of 
activated T cells, AP-1, and negative, YY1 and LSF, transcriptional regulators. Tumor 
necrosis factor- (TNF-) and other cytokines can induce NF-kb and activate HIV-1 
transcription in infected cells (Van Lint, et al., 2004). Transcription regulation of the HIV-1 
genome is mediated by RNA polymerase II (RNAP II) and a combination of basal and 
promoter specific factors (Fig. 2) (Brady & Kashanchi, 2005, Pereira, et al., 2000).  
Shortly after transcription begins RNAP II activity is paused. Before transcription is halted a 
short (nucleotides +1 to +82) stem loop sequence, the transactivation responsive (TAR) 
RNA, is synthesized. Binding of the 101 amino acid viral regulatory protein Tat to TAR 
stimulates transcription elongation and possibly initiation of the viral transcription complex 
(Fig. 2) (Berkhout, et al., 1989, Gaynor, 1995, Raha, et al., 2005). The Tat-TAR interaction 
promote the recruitment of the cyclin T1 (CycT1) component of the human positive 
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transcription elongation factor b (P-TEFb) (Garber, et al., 1998, Wei, et al., 1998). CycT1 recruits 
Cdk9, the catalytic subunit of P-TEFb, which phosphorylates the C-terminal domain (CTD) of 
RNAP II to facilitate elongation of the viral transcript (Bres, et al., 2008, Peterlin & Price, 2006). 
The mammalian RNAPII CTD is composed of 52 tandemly repeated heptads with a 
consensus, Tyr-1-Ser-2-Pro-3-Thr-4-Ser-5-Pro-6-Ser-7. Ser-2 and Ser-5 are targets of 
phosphorylation and dephosphorylation during transcription (Hirose & Ohkuma, 2007). 
Phosphorylation of RNAPII CTD is essential for transcription. RNAPII CTD is phosphorylated 
at Ser-5 by TFIIH (CDK7) during transcription initiation through the promoter clearance stage 
(Hengartner, et al., 1998) and changes to Ser-2 phosphorylation during elongation when the 
polymerase is associated with the coding region (Komarnitsky, et al., 2000, Ni, et al., 2004). In 
addition to promoting Ser-2 phosphorylation, Tat modifies the activity of CDK9 to 
phosphorylate Ser-5 following release of TFIIH (Zhou, et al., 2000). Furthermore, P-TEFb 
targets cofactors such as the human homologoue of SPT5 (TAT-CT1), which together with 
SPT4 constitutes the 5,6-dichloro-1-ß-D-ribofuranosylbenzimidazole sensitivity-inducing 
factor (DSIF) and the negative elongation factor (NELF) Rd protein (Yamaguchi, et al., 1999). 
The cooperative interaction of DSIF and NELF induce polymerase pausing near promoter start 
sites (Wada, et al., 2000, Wada, et al., 1998b). This pausing event can be reversed by a CDK9-
dependent phosphorylation of SPT5 (Kim & Sharp, 2001) and the RD protein, which causes a 
dissociation of NELF from the stem of TAR RNA (Fujinaga, et al., 2004).  
 
 
Fig. 2. A) The map shows the genomic organization of the HIV-1 provirus indicating the 
position of the various viral genes and key features of the viral genome. B) Schematic 
representation of viral transcription. A number of cellular transcription factors assemble 
onto the LTR promoter. Binding of Tat onto the TAR sequence promotes assembly of the 
components of P-TEFb (CycT1 and CDK9). The kinase activity of CDK9 phosphorylates the 
RNAPII CTD to facilitate elongation.  
Tat role in viral transcription is not limited to the recruitment of RNAP II cofactors. Once 
integrated into the host cell genome, nucleosomes are deposited at specific positions within 
the viral promoter and exert a strong repression of transcriptional initiation. After Tat 
activates transcription, the chromatin associated with sequences immediately downstream 
of the transcription start site becomes accessible to nucleases (Verdin, et al., 1993). The 
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chromatin remodeling induced by Tat is dependent on the recruitment of enzymes with 
histone acetyl transferase (HAT) activity, which modify chromatin conformation (Marcello, 
et al., 2001). These factors include the transcriptional co-activators p300 and the cAMP-
responsive binding protein (CREB)-binding protein (CBP) (Marzio, et al., 1998), the 
p300/CBP-associated factor (P/CAF) (Benkirane, et al., 1998), the general control non-
derepressible-5 (GCN5) factor (Col, et al., 2001), the transcription factor TAFII250 
(Weissman, et al., 1998) and the TIP60 protein (Kamine, et al., 1996). HATs acetylate the N-
terminal tails of histones to stimulate chromatin remodeling and modify specific lysines of 
transcription factors to modulate DNA-binding affinity (Li, et al., 2007, Yang & Seto, 2008). 
In addition to histones, Tat itself is a substrate for acetylation by HATs. Lysines at positions 
50 and 51 are major substrates for acetylation by p300 and hGCN5 (Col, et al., 2001, Deng, et 
al., 2001, Kiernan, et al., 1999). Acetylation of lysine 50 of Tat promotes the dissociation of 
Tat from TAR RNA during early transcription elongation and recruitment of the SWI/SNF 
chromatin-remodeling complex (Treand, et al., 2006), which synergize with p300 
acetyltransferase and acetylated Tat to remodel the nucleosome at the HIV promoter in 
order to activate transcription (Mahmoudi, et al., 2006). Furthermore, acetylation of lysine 50 
triggers the recruitment of P/CAF to the elongating RNA Pol II (Dorr, et al., 2002). P/CAF 
acetylates Tat on Lys28 (Kiernan, et al., 1999), which enhances the Tat-CycT1 interaction 
(Bres, et al., 2002). Besides acetylation other post-translational modifications appear to 
regulate Tat activity. Phosphorylation of Tat Ser16 and Ser46 by the cell cycle regulator 
Cdk2/cyclin E appears to be required for efficient HIV-1 transcription and replication 
(Ammosova, et al., 2006). Methylation of Tat on arginine residues by PRMT6 has been 
shown to inhibit transcriptional activity (Boulanger, et al., 2005), while non-proteolytic 
ubiquitination of Tat by Hdm2 appears to enhance viral transcription (Bres, et al., 2003). 
In addition to its role in viral transactivation, Tat has also been shown to regulate the rate of 
transcription and expression of host cellular genes (Caldwell, et al., 2000, Gibellini, et al., 
2002, Huang, et al., 1998, Ott, et al., 1998, Secchiero, et al., 1999). Furthermore, Tat function 
appears not to be restricted to infected cells, which actively secrete large amounts of Tat in 
the bloodstream (Ensoli, et al., 1990). Extracellular Tat can generate a wide array of cell 
responses ranging from T-cell activation (Wu, et al., 2007) to stimulation of cytokine 
secretion, cell death in neurons and cell proliferation in endothelial and T-cells (Huigen, et 
al., 2004, King, et al., 2006, Rubartelli, et al., 1998). The mechanism by which Tat exerts these 
pleiotropic effects is still unclear.  
3. HIV-1 mRNA processing 
Before a gene transcript is ready to be transported out of the nucleus it has to be processed 
by acquiring a cap structure at the 5’ terminus, introns have to be spliced out and a 3’ end is 
generated by adding a poly(A) tail. Although these reactions are biochemically distinct 
processes, they are interlinked and influence one another’s specificity and efficiency. Most 
mechanisms regulating the processing of viral transcripts are common to most cellular 
mRNAs, nevertheless some processes, such as the export of the unspliced and partially 
spliced mRNAs to the cytoplasm, are unique for the virus. 
3.1 Capping 
mRNA capping is carried out by a series of enzymatic reactions in which the 5’ triphosphate 
terminus of the pre-mRNA is cleaved to a diphosphate by a RNA triphosphatase (RTP), then 
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capped with GMP by RNA guanylyltransferase (GT), and methylated by RNA (guanine-N7) 
methyltransferase (MT). Targeting of Cap formation to transcripts made by RNAP II is 
achieved through the interaction of the capping enzymes with the phosphorylated RNAPII 
CTD.  The Cap structure is recognized by the Cap binding complex (CBC), which contains 
the proteins, CBP20 and CBP80 (Proudfoot, et al., 2002, Shatkin & Manley, 2000).  HIV-1 
capping takes place during the transition from transcription initiation to elongation when 
the nascent pre-mRNA is only 20–40 nucleotides long. Tat promotes viral mRNA Cap 
formation by inducing TAR-dependent phosphorylation of RNAPII CTD (Chiu, et al., 2002, 
Zhou, et al., 2003) Phosphorylation of the CTD Ser-2 and Ser-5 residues has differential 
effects on recruitment and activation of capping enzymes (Bentley, 2002, Proudfoot, et al., 
2002).  Although Ser-2 phosphorylation of CTD heptads is sufficient for mammalian GT 
binding, its activation requires Ser-5 phosphorylated CTD (Ho & Shuman, 1999). 
3.2 3’ end formation  
In higher eukaryotes, with the exception of histone genes, all protein encoding mRNAs 
contain a uniform 3’ end consisting of 200-400 adenosine residues. The poly(A) tail 
regulates degradation of the mRNA and translation. The formation of the poly (A) tail is 
directed by sequences present on the pre-mRNA and the mammalian polyadenylation 
machinery.  Prior to the addition of poly(A), the pre-mRNA must be cleaved. The site of 
cleavage, in most pre-mRNAs, lies between a highly conserved AAUAAA hexamer and a 
downstream sequence element (DSE), which is a U- or GU-rich motif. The cleavage/ 
poly(A) complex consists of cleavage factors (CPSF, CstF, CF) and the poly(A) polymerase 
(PAP). RNA is first cleaved ~10 to 30 nts 3' to AAUAAA, predominantly at a CA 
dinucleotide, than the PAP synthesizes a polyA tail using ATP as substrate (Proudfoot, et 
al., 2002, Shatkin & Manley, 2000). 
HIV-1 encodes the polyadenylation signal within the repeat (R) region, which is present at 
the extreme 5' and 3' end of the viral transcript. Thus the 5' polyadenylation signal needs to 
be repressed while usage of the 3’ one needs to be enhanced. Usage of the 3' 
polyadenylation site is promoted by an upstream enhancer (USE) motif, which stabilizes 
binding of the cleavage polyadenylation specificity factor (CPSF) to the AAUAAA 
(Gilmartin, et al., 1995). The 5' HIV-1 polyadenylation site is repressed because it is 
positioned too close to the transcription initiation site and polyadenylation factors have not 
yet gained access to the nascent transcript through the RNAP II complex (Cherrington & 
Ganem, 1992, Weichs an der Glon, et al., 1991). Moreover, binding of U1 snRNP to the major 
splice donor site, which is located downstream of 5' R, represses polyadenylation at the 5' 
polyadenylation signal (Ashe, et al., 1995, Ashe, et al., 1997). Cellular proteins can play a role 
in regulating cleavage and polyadenylation of HIV-1 RNA. hnRNP U has been shown to be 
involved in the post-transcriptional regulation of viral RNA via interactions with the 3’ UTR 
(Valente & Goff, 2006). The STAR (signal transduction and activation of RNA) protein 
family member Sam68 enhances HIV-1 gene expression and this effect may be due in part to 
Sam68’s ability to stimulate cleavage of unspliced viral RNA (McLaren, et al., 2004, Reddy, 
et al., 1999).  Experimental evidence also indicates a role for viral proteins in regulating the 
host polyadenylation machinery to render the cell more supportive of virus replication. The 
accessory protein Vpr induces polyA polymerase dephosphorylation and its subsequent 
activation (Mouland, et al., 2002), while Tat increases the expression of the cleavage and 
polyadenylation specificity factor (CPSF) (Calzado, et al., 2004).  
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3.3 mRNA Splicing 
The removal of intronic sequences in the nascent transcript is carried out by large 
multicomponent ribonucleoprotein complex, the spliceosome, constituted by five small 
nuclear ribonucleoprotein complexes (snRNPs, U1, U2, U4, U5, U6), which assembly onto 
the pre-mRNA requires auxiliary proteins called splicing factors (Moore, et al., 1993). The 
process of splicing involves recognition of short loosely conserved sequences flanking the 
introns. The U1 snRNP recognizes the 5’ splice site (5’ss) while the U2 snRNP in 
combination with the splicing factor U2AF65/35 recognizes sequences at the 3’ splice site 
(3’ss). 5' and 3' splice sites are required for splicing but alone are not sufficient for the proper 
recognition of exonic and intronic sequences.  
 
 
Fig. 3. A) The map shows the HIV-1 open reading frames. B) A single pre-mRNA of 9.2 kb is 
transcribed by the virus. 5’ and 3’ splice sites are indicated The unspliced viral mRNA codes 
for the Gag/Pol gene products. 5’ and 3’ splice sites are indicated. Splicing silencers 
(intronic and exonic) and splicing enhancers (intronic and exonic) are indicated. (*) marks 
the location of the GAR splicing enhancer (see Fig 5). C) Prevalent spliced viral mRNas. 
Over 40 alternatively spliced mRNAs are originated by the alternative usage of the multiple 
5’ and 3’ splice sites, the most abundant mRNA isoforms are indicated with their 
approximate size and the splice site utilized to generate them.  
Additional regulatory elements are classified as either exonic and intronic splicing 
enhancers (ESE and ISE) or exonic and intronic splicing silencers (ISS and ESS). These 
sequences can interact with factors that promote proper recognition of the splice sites and 
regulate splicing in response to physiological stimuli. Among the best-characterized ESEs 
are purine-rich sequences that recruit members of the serine/arginine-rich (SR) family of 
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splicing activators (Blencowe, 2000). SR proteins regulate splicing by binding enhancer 
elements and recruiting and stabilizing components of the core splicing machinery to 
nearby splice sites (Graveley, 2000). Recent work implicates SR proteins in additional steps 
of gene expression, including mRNA export, stability, quality control and translation 
(Huang & Steitz, 2005). The best-known ESSs are dependent on interactions with members 
of the heterogenous ribonucleoprotein A/B family (hnRNPs A/B) (Krecic & Swanson, 1999). 
Positive and negative cis-acting sequences are often organized in multipartite control 
elements where SR proteins and hnRNPs often play counteracting roles (Caceres, et al., 
1994, Han, et al., 2005, Zahler, et al., 2004). 
Alternative splicing is a process common to most cellular mRNAs by which exons from a 
primary transcript (pre-mRNA) can be spliced in different arrangements to yield mRNAs 
that will produce functionally different protein variants (Black, 2003). The primary viral 
transcript undergoes a complex series of splicing events to generate over 40 mRNA 
isoforms, thus, the same viral protein is encoded by multiple mRNAs that vary for their 5’ 
and 3’ untranslated regions. Spliced viral mRNAs can be classified in a group of 
approximately 4kb in length, coding for the Env, Vpu, Vpr and Vif proteins, and a group of 
approximately 2 kb in length, coding for the Tat, Rev, Vpr and Nef proteins (Fig. 3C) 
(Purcell & Martin, 1993). Furthermore, approximately 50% of the viral pre-mRNAs leave the 
nucleus without being spliced. The unspliced 9 kb mRNA codes for the Gag and Gag-Pol 
polyprotein and is packaged within the nascent virions as viral genome. Alteration of this 
complex splicing pattern can have profound effects on viral replication and infectivity 
(Amendt, et al., 1994, Jablonski, et al., 2008, Jacquenet, et al., 2005, Purcell & Martin, 1993). 
HIV-1 splicing regulation relies on the presence of multiple viral regulatory sequences as 
well as cellular splicing factors that interact with these elements. To date, 4 exonic splicing 
silencers (ESS), 1 intronic splicing silencer (ISS), 1 intronic splicing enhancer (ISE) and 6 
splicing exonic enhancers (ESE) have been identified (Fig. 3B) (Exline, et al., 2008, McLaren, 
et al., 2008, Schaub, et al., 2007). Several SR proteins (SC35, SF2, SRp40, 9G8) have been 
shown to bind the viral splicing enhancers and regulate splicing, while members of the 
hnRNP A/B (A1, A2 and A3) family have been shown to inhibit the usage of viral splice 
sites by binding viral spicing silencer elements and counteracting the activity of SR proteins 
(McLaren, et al., 2008). A third group of proteins interacts with both, enhancer and silencer 
sequences, is the hnRNP H family (H’, F, 2H9 and GRSF1). These are highly homologous 
and ubiquitously expressed factors, which regulate splicing, polyadenylation, capping, 
export and translation of cellular and viral mRNAs (Fogel & McNally, 2000, Han, et al., 
2005, Jablonski & Caputi, 2009, Min, et al., 1995, Schaub, et al., 2007).  
Cis-acting splicing regulatory elements within the HIV genome are highly heterogenous, 
redundant and provide for ample regulation of viral genome expression. In addition, the 
virus appears to directly regulate the relative amount and activity of cellular splicing factors 
in infected cells. HIV-1 infection has been shown to induce alteration in SR protein 
subcellular distribution, and activity via modificaton of their phosphorylation state by SR-
specific kinases (Fukuhara, et al., 2006). Furthermore, data obtained from infected 
monocyte-derived macrophages demonstrate that a peak in viral production results in 
down-regulation of members of the hnRNP A/B, H and SR family, thus confirming the 
critical role that these proteins may play in viral replication. (Dowling, et al., 2008). 
3.4 mRNA export and stability 
In the early phase of viral infection the 2 kb class of viral RNAs (translated into Tat, Rev and 
Nef) is exported to the cytoplasm while 9 and 4 kb viral RNAs are retained in the nucleus. 
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Nuclear retention of 9 and 4 kb HIV-1 RNAs has been attributed to either partial 
spliceosome assembly (Chang & Sharp, 1989) or to a series of of poorly characterized 
sequences called the instability (INS) or cis-acting repressor (CRS) sequences (Maldarelli, et 
al., 1991, Mikaelian, et al., 1996, Nasioulas, et al., 1994, Olsen, et al., 1992) present within the 
viral mRNA. These sequences restrict the expression of the 9 kb and 4 kb mRNA species. 
The mechanistic details of inhibition of gene expression by INS/CRS remains obscure, it has 
been proposed to involve increased splicing efficiency, prevention of nuclear export and 
degradation of INS/CRS containing RNAs or a combination thereof (Boris-Lawrie, et al., 
2001, Reddy, et al., 2000, Wodrich & Krausslich, 2001). The fully spliced 2 kb mRNAs are 
exported from the nucleus to the cytoplasm with a mechanism similar to the one utilized by 
the assembly of a protein complex at the junctions between exons (exon junction complex, 
EJC) during splicing (Rodriguez, et al., 2004). Additionally, factors directly binding to 
sequences within the RNA may contribute to efficient export (Huang & Steitz, 2005). 
  
 
Fig. 4. HIV-1 RNA export to the cytoplasm. 9 and 4 kb viral RNAs are exported to the 
cytoplasm upon interaction of the Rev/Crm1/RanGTP complex with the RRE sequence 
within the RNA. The DDX1 and DDX3 helicases facilitate translocation of the Rev-RNA 
complex to the cytoplasm through the nuclear pore complex (NPC). Other host cell factors 
have positive (hRIP, SAM68, eIF-5a) or negative (NF90ctv, PRMT6) effects on the Rev-
dependent export of the viral RNA but their role is less understood. Importin-b, RanGDP 
and B24 are required for import of Rev into the nucleus.  
Nuclear retention of the unspliced and partially spliced viral mRNAs (9 and 4 kb) is 
overcome by the viral protein Rev, which is imported into the nucleus and binds to an RNA 
element within the env gene, called the Rev Responsive Element (RRE), and mediates 
nuclear export and efficient expression of its target RNAs (Fig. 4) (Cullen, 2000, Cullen, 
2003). All the 4kb and 9kb viral mRNA species contain the RRE element and in the absence 
of Rev are poorly expressed in the cytoplasm. Rev import from the cytoplasm into the 
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nucleus is aided by importin- and the nuclear phosphoprotein B23. Following Rev binding 
to the RRE, the nuclear export factors CRM1 and Ran-GTP are recruited to the complex to 
promote export of the viral RNA into the cytoplasm. The Rev-RRE-CRM1-RanGTP RNA 
complex is finally dissociated in the cytoplasm upon conversion of RanGTP to RanGDP 
(Suhasini & Reddy, 2009). 
Little is known of cellular co-factors required by Rev-RRE other than the general nuclear 
export factors exportin CRM1 and RAN-GTP. RNA helicases DDX1 and DDX3 are known 
to associate with the Rev-CRM1-RRE complex and are postulated to aid the egress of the 
viral RNA through the nuclear pore by remodeling its structure (Fang, et al., 2004, 
Yedavalli, et al., 2004). Other factors such as the eukaryotic initiation factor eIF-5A (Bevec, 
et al., 1996, Ruhl, et al., 1993), the human Rev interacting protein (hRIP) (Bogerd, et al., 
1995, Fritz, et al., 1995) and Sam68 (Reddy, et al., 1999) have also been shown to enhance 
Rev activity although their mechanism is still unclear. Cellular factors may also play an 
inhibitory role in Rev-dependent RNA export. The C-terminal variant of nuclear factor 90 
(NF90ctv) has been shown to reduce Rev function by binding and partially relocalizing 
Rev to the cytoplasm (Urcuqui-Inchima, et al., 2006), while Rev methylation by the 
arginine methylase PRMT6 reduces Rev binding to the RRE and blocks viral RNA export 
(Invernizzi, et al., 2006). 
4. Transcription and mRNA processing coupling 
In recent years our view of gene expression has changed significantly. While a growing 
number of genetic studies have revealed functional links between the factors that carry out 
the different steps in the gene expression pathway, conventional biochemical approaches 
and large-scale mapping of protein-protein interaction networks have uncovered physical 
interactions between the various machineries (Orphanides & Reinberg, 2002, Proudfoot, et 
al., 2002). The transcriptional apparatus plays an active role in recruiting the machinery that 
processes the nascent RNA transcript (Bentley, 2002, Bentley, 2005). The RNAPII CTD 
operates as a binding platform for components of the RNA processing machineries and its 
phosphorylation regulates the activity of the capping enzymes, assembly of the spliceosome 
and the binding of the cleavage/polyadenylation complex (Buratowski, 2003, Fong & 
Bentley, 2001, Hirose & Ohkuma, 2007, Komarnitsky, et al., 2000, Proudfoot, et al., 2002). 
The mechanism coupling 5’ RNA capping with transcription has been well studied. Binding 
of the DSIF factor (Wada, et al., 1998a, Wada, et al., 1998b) to RNAPII shortly after initiation 
recruits NELF (Yamaguchi, et al., 1999), which arrests transcription. The cdk7 subunit of the 
initiation factor TFIIH phosphorylates the RNAPII CTD Ser-5 between initiation and arrest 
(Woychik & Hampsey, 2002). The paused RNAP II is then joined by the capping enzymes 
through interactions with the Ser-5 phosphorylated CTD and DSIF (Wada, et al., 1998b, Wen 
& Shatkin, 1999). Following the addition of the Cap, the kinase activity of P-TEFb 
phosphorylates DSIF (Ivanov, et al., 2000, Kim & Sharp, 2001), this neutralizes the repressive 
action of NELF and allows the polymerase to resume elongation. Similary 3' End formation 
is also linked to transcription. The cleavage/polyadenylation factors CPSF and CstF are 
transferred by the RNAP II CTD to their specific pre-mRNA-binding sites to produce the 
mRNA 3' end (Buratowski, 2005). Splicing and 3’ end formation machineries are also 
connected since repression of the polyadenylation signal within the R5 region is dependent 
on proximity to the promoter and recognition of the major 5’ splice site by the U1 snRNP 
(Ashe, et al., 1995, Ashe, et al., 1997). 
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Several studies have also shown that transcription and splicing are closely connected 
processes. The rate of elongation, the promoter type, transcriptional activators and the 
chromatin remodeling factors nearby can all affect splicing of a pre-mRNA (Batsche, et al., 
2006, de la Mata, et al., 2003, Kornblihtt, 2005, Kornblihtt, 2007). Again, the RNAPII CTD 
assumes a central role in the regulation of RNA splicing. Phosphorylation at Ser-2 position 
of the RNAPII CTD stimulates pre-mRNA splicing (Hirose, et al., 1999, Misteli & Spector, 
1999). Studies have identified several splicing factors that interact either directly or 
indirectly with the transcription machinery (Kameoka, et al., 2004, Kwek, et al., 2002). Many 
of the works published indicate processes that link the transcription machinery to pre-
mRNA splicing. However, a “reverse coupling” mechanism, whereby pre-mRNA splicing 
exerts an influence on transcription has also been described. Indeed, the SR protein SC35 has 
been shown to affect transcription elongation (Lin, et al., 2008) and promoter-proximal 5´ 
splice sites increase transcription initiation via recruitment of the transcription preinitiation 
complex (PIC) (Damgaard, et al., 2008).  
Studies on the association between the viral transcription and splicing machinery are still in 
their infancy. Research indicates that the cellular factor Tat-SF1, which is required for efficient 
transcriptional transactivation of the viral genome (Parada & Roeder, 1999, Zhou & Sharp, 
1996), is also interacting with spliceosomal components (Fong & Zhou, 2001).  The association 
with both elongation and splicing factors has led to the suggestion that Tat-SF1 can couple 
these two processes. Tat-SF1 also binds to another transcription-splicing coupling factor, 
CA150 (TCERG1) (Smith, et al., 2004). Over-expression of CA150 has been shown to reduce the 
ability of Tat to mediate viral transcription (Sune & Garcia-Blanco, 1999). This function is 
dependent on the association of CA150 with pre-mRNA splicing factors and RNAPII CTD 
(Carty, et al., 2000, Goldstrohm, et al., 2001) and may bridge splicing complexes to actively 
transcribing RNAPII (Sanchez-Alvarez, et al., 2006). The cellular protein c-Ski-interacting 
protein, SKIP, has been shown to regulate Tat-dependent viral transcription and interact with 
the splicing associated U5 snRNP and the tri-snRNP 110K protein (Bres, et al., 2005). Studies 
also indicate the presence of a reverse coupling mechanism in HIV-1. U1 snRNA binding to a 
specific 5’ splice site within the viral genome appears to overcome a checkpoint for elongation 
present in the env gene intron (Alexander, et al. 2010). 
The viral transactivator Tat has also been shown to regulate viral splicing through the 
ASF/SF2 inhibitor p32 (Berro, et al., 2006). p32 is recruited to the HIV-1 promoter by the 
acetylated form of Tat, suggesting a mechanism by which acetylation of Tat promotes 
binding of p32 and thereby inhibits HIV-1 splicing, thus increasing the amounts of 
unspliced transcripts available for being translated into gag/pol gene products and 
packaging into the nascent virions as viral genome. More recently we have shown that Tat is 
also a selective mediator of HIV-1 splicing (Jablonski, et al., 2010) via the recruitment of the 
cellular co-transcriptional splicing activators Tat-SF1 and CA150 (Fig. 5). The Tat-
transcription-splicing complex activates a distal splicing enhancer (GAR), which is required 
for env mRNA expression.  In the context of the full-length viral genome, this mechanism 
promotes an autoregulatory feedback that decreases expression of Tat-coding mRNAs and 
favors expression of Env-specific mRNAs. Tat-mediated splicing does not appear to be 
dependent on its transcriptional activity. Substitution of the LTR promoter for the 
heterologous -globin, promoter or down-regulation of Tat transcription co-factors SKIP and 
Tat-CT1 blocks Tat-mediated transactivation but not splicing. Tat appears to modulate 
splicing independent of its ability to functionally engage the transcription machinery and 
alter phosphorylation of the RNAP II CTD, defining a novel mechanism that couples 
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transcription and RNA processing via the direct recruitment of splicing factors through 
transcription activators. We have also shown that, like Tat, mammalian transcriptional co-
activators of the Torc family can also activate splicing of endogenous genes and that this 
activity is independent from their role in transcription (Amelio, et al., 2009). These 
observations provide support for a general mechanism whereby transcriptional activators, 
viral or cellular, can selectively regulate splicing processes.  
 
 
Fig. 5. Model for Tat-mediated splicing. Tat binding to TAR helps the recruitment of Tat-SF1 
and CA150, which stimulates the assembly of the splicing factor SF2 onto the GAR enhancer 
(see Fig. 2). SF2 interaction with GAR promotes the upstream 3’ss and recruitment of U1 
snRNP to the downstream 5’ss, which promotes expression of the env specific mRNA. 
5. HIV-1 derived microRNAs  
MicroRNAs (miRNAs) are short non-coding RNA molecules encoded by most eukaryotic 
life forms ranging from plants to higher order mammals. miRNAs have multiple pre- and 
post-transcriptional roles in the regulation of gene expression. The first step in the 
biogenesis of miRNA is the nuclear processing of primary RNA transcripts (pri-miRNAs) 
approximately 80 nucleotide long into shorter (~60nt) pre-miRNAs, which are exported to 
the cytoplasm where pre-miRNA are further processed into mature miRNAs and assembled 
into a ribonucleoprotein complex named RISC (RNA-induced silencing complex) (Chua, et 
al., 2009, Perron & Provost, 2008, Winter, et al., 2009). The RISC complex and the associated 
miRNA often contain sequences complementary to the 3’ UTR region of the target mRNAs. 
Perfect complementarity between the target sequence and the miRNA triggers degradation 
of the target RNA. However, when miRNA and target mRNA sequences are only partially 
complementary the mRNA is translationaly repressed. Furthermore, miRNA can also 
operate at chromatine level. miRNAs have been shown to associate with the RNA-induced 
initiation of transcriptional silencing (RITS) complex and be recruited to complementary 
sequences in the chromosomal DNA. This promotes the activity of histone modifying 
enzymes, which alter the chromatin structure and induce transcriptional silencing (Buhler & 
Moazed, 2007, Verdel, et al., 2004). 
Several HIV-1 encoded non-coding RNAs have been identified. In particular, the stem-loop 
TAR sequence is structurally similar to a pre-miRNA and it has been shown to be processed 
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into two functional miRNAs, the 5’ stem (miR-TAR-5p) and the 3’ stem (miR-TAR-3p) 
(Klase, et al., 2007, Klase, et al., 2009, Ouellet, et al., 2008).  miR-TAR-3p acts as an inhibitor 
of cellular gene expression targeting genes regulating stress induced cell death (Klase, et al., 
2009). The downregulation of the host machinery by viral miRNAs is part of the viral 
strategies to prolong the life span of an infected cell and allows for efficient viral replication 
and the emergence of latently infected cells. Additionally, it has been shown that the TAR-
derived miRNA can downregulate gene expression by recruiting chromatin remodeling 
components, thus inducing transcriptional silencing via the RITS mechanism (Purzycka & 
Adamiak, 2008). 
A second miRNA is coded within the viral gene nef. Nef is a viral protein required for 
productive viral infection. It has been shown that miRNAs derived from nef transcripts are 
present in HIV-1 infected cells (Yamamoto, et al., 2002). Nef derived miRNAs appear to 
down regulate expression of the nef gene and they appear to be present in higher amounts in 
HIV-1 patients that are long time non-progressors and display low viremia. 
A third miRNA generated by HIV-1, named miR-H1, is an 81 nucleotide stem loop structure 
present downstream of the two NF-kB sites in the LTR (Bennasser, et al., 2004). MiR-H1 has 
been shown to degrade the apoptosis antagonizing transcription factor (AATF) (Kaul, et al., 
2009), which leads to lowered cell viability, thus counteracting the anti-apoptotic effect of 
the TAR-derived miRNAs. Furthermore, miR-H1 down regulates expression of the cellular 
miRNA miR149, which targets the Vpr gene encoded by HIV-1 (Kaul, et al., 2009). Studies 
on HIV-1 miRNA variability in different viral isolates have also shown that there is a strong 
correlation between specific miR-H1 sequences and the development of HIV-1-associated 
dementia and AIDS related lymphoma (Lamers, et al., 2009).  
In addition to generating several viral miRNAs, HIV also regulates the cellular machinery 
that process small non-coding RNAs. The viral protein Tat appears to act as a generic 
suppressor of the activity of Dicer (Bennasser, et al., 2005), a key enzyme required for the 
maturation of small non-coding RNAs. Furthermore, the viral proteins Vpr and Nef have 
been shown to suppress the cellular miRNA machinery by suppressing production of Dicer 
(Coley, et al., 2011). Vertebrates have developed RNAi-based antiviral mechanisms. Given 
the presence in the HIV-1 genome of multiple regions that produce interfering RNAs, the 
anti-RNA silencing function of several viral proteins appears to be required to sustain viral 
replication in infected cells. 
6. Future prospective 
Different aspects of viral replication have been the targets of therapeutics; nevertheless, few 
efforts have been aimed at the disruption of the mechanism regulating viral RNA 
biogenesis. Formation of the HIV-1 transcript provides an important model for human RNA 
processing pathways and can be crucial in the isolation of novel therapeutic targets to block 
viral replication. Cellular factors regulating HIV RNA are expressed in most cell types and 
regulate a multitude of cellular splicing events theoretically making them less ideal 
therapeutic target candidates. Nevertheless, several drugs inhibiting different aspects of Tat 
transactivation are currently being tested. Different classes of compounds have been shown 
to specifically inhibit viral transcription by: (i) binding the TAR sequence, (ii) binding Tat, 
(iii) inhibiting PTEF-b components and (iv) generally inhibiting transactivation by 
mechanisms not yet well defined (Giacca, 2004). Small molecules that inhibit the splicing 
activity of SR proteins have also been shown to efficiently repress viral replication in 
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peripheral blood mononuclear cells (PBMC) with little cell toxicity (Bakkour, et al., 2007). 
Furthermore, the possibility of utilizing delivery systems that specifically target cells 
infected by the virus (Neff, et al., 2011, Peretti, et al., 2006) suggest that cellular factors 
regulating the making of the viral RNA can be efficiently targeted to inhibit viral replication. 
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